Literature DB >> 31913998

Fibroblast Growth Factor 21 Is Elevated in HIV and Associated With Interleukin-6.

Allison Ross Eckard1, Heather Y Hughes1,2, Nancy L Hagood1, Mary A O'Riordan3,4, Danielle Labbato3, Julia C Kosco3, Sarah E Scott3, Grace A McComsey3,4.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2020        PMID： 31913998      PMCID： PMC7153762          DOI： 10.1097/QAI.0000000000002285

Source DB:  PubMed          Journal:  J Acquir Immune Defic Syndr        ISSN： 1525-4135            Impact factor:   3.771


× No keyword cloud information.
  57 in total

1.  Markers of inflammation, coagulation, and renal function are elevated in adults with HIV infection.

Authors:  Jacqueline Neuhaus; David R Jacobs; Jason V Baker; Alexandra Calmy; Daniel Duprez; Alberto La Rosa; Lewis H Kuller; Sarah L Pett; Matti Ristola; Michael J Ross; Michael G Shlipak; Russell Tracy; James D Neaton
Journal:  J Infect Dis       Date:  2010-06-15       Impact factor: 5.226

2.  Pegbelfermin (BMS-986036), a PEGylated fibroblast growth factor 21 analogue, in patients with non-alcoholic steatohepatitis: a randomised, double-blind, placebo-controlled, phase 2a trial.

Authors:  Arun Sanyal; Edgar D Charles; Brent A Neuschwander-Tetri; Rohit Loomba; Stephen A Harrison; Manal F Abdelmalek; Eric J Lawitz; Dina Halegoua-DeMarzio; Sudeep Kundu; Stephanie Noviello; Yi Luo; Rose Christian
Journal:  Lancet       Date:  2018-12-13       Impact factor: 79.321

3.  FGF-21 as a novel metabolic regulator.

Authors:  Alexei Kharitonenkov; Tatiyana L Shiyanova; Anja Koester; Amy M Ford; Radmila Micanovic; Elizabeth J Galbreath; George E Sandusky; Lisa J Hammond; Julie S Moyers; Rebecca A Owens; Jesper Gromada; Joseph T Brozinick; Eric D Hawkins; Victor J Wroblewski; De-Shan Li; Farrokh Mehrbod; S Richard Jaskunas; Armen B Shanafelt
Journal:  J Clin Invest       Date:  2005-05-02       Impact factor: 14.808

4.  Effects of lifestyle modification and metformin on irisin and FGF21 among HIV-infected subjects with the metabolic syndrome.

Authors:  Suman Srinivasa; Kimberly Wong; Kathleen V Fitch; Jeffrey Wei; Eva Petrow; Aaron M Cypess; Martin Torriani; Steven K Grinspoon
Journal:  Clin Endocrinol (Oxf)       Date:  2014-10-08       Impact factor: 3.478

5.  Fibroblast growth factor 21 participates in adaptation to endoplasmic reticulum stress and attenuates obesity-induced hepatic metabolic stress.

Authors:  Seong Hun Kim; Kook Hwan Kim; Hyoung-Kyu Kim; Mi-Jeong Kim; Sung Hoon Back; Morichika Konishi; Nobuyuki Itoh; Myung-Shik Lee
Journal:  Diabetologia       Date:  2014-12-24       Impact factor: 10.122

6.  Role of fibroblast growth factor 21 in the early stage of NASH induced by methionine- and choline-deficient diet.

Authors:  Naoki Tanaka; Shogo Takahashi; Yuan Zhang; Kristopher W Krausz; Philip B Smith; Andrew D Patterson; Frank J Gonzalez
Journal:  Biochim Biophys Acta       Date:  2015-02-28

7.  HIV infection and the risk of acute myocardial infarction.

Authors:  Matthew S Freiberg; Chung-Chou H Chang; Lewis H Kuller; Melissa Skanderson; Elliott Lowy; Kevin L Kraemer; Adeel A Butt; Matthew Bidwell Goetz; David Leaf; Kris Ann Oursler; David Rimland; Maria Rodriguez Barradas; Sheldon Brown; Cynthia Gibert; Kathy McGinnis; Kristina Crothers; Jason Sico; Heidi Crane; Alberta Warner; Stephen Gottlieb; John Gottdiener; Russell P Tracy; Matthew Budoff; Courtney Watson; Kaku A Armah; Donna Doebler; Kendall Bryant; Amy C Justice
Journal:  JAMA Intern Med       Date:  2013-04-22       Impact factor: 21.873

8.  Serum concentrations and tissue expression of a novel endocrine regulator fibroblast growth factor-21 in patients with type 2 diabetes and obesity.

Authors:  M Mraz; M Bartlova; Z Lacinova; D Michalsky; M Kasalicky; D Haluzikova; M Matoulek; I Dostalova; V Humenanska; M Haluzik
Journal:  Clin Endocrinol (Oxf)       Date:  2008-12-11       Impact factor: 3.478

9.  Fibroblast growth factor 21 corrects obesity in mice.

Authors:  Tamer Coskun; Holly A Bina; Michael A Schneider; James D Dunbar; Charlie C Hu; Yanyun Chen; David E Moller; Alexei Kharitonenkov
Journal:  Endocrinology       Date:  2008-08-07       Impact factor: 4.736

10.  Fibroblast growth factor 21 predicts the metabolic syndrome and type 2 diabetes in Caucasians.

Authors:  Thomas Bobbert; Franziska Schwarz; Antje Fischer-Rosinsky; Andreas F H Pfeiffer; Matthias Möhlig; Knut Mai; Joachim Spranger
Journal:  Diabetes Care       Date:  2012-08-28       Impact factor: 19.112
View more
  1 in total

Review 1.  Non-Alcoholic Fatty Liver Disease in HIV/HBV Patients - a Metabolic Imbalance Aggravated by Antiretroviral Therapy and Perpetuated by the Hepatokine/Adipokine Axis Breakdown.

Authors:  Simona Alexandra Iacob; Diana Gabriela Iacob
Journal:  Front Endocrinol (Lausanne)       Date:  2022-03-09       Impact factor: 5.555
  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.